ALLOVIR
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases. It provides an ideal environment for ViraCyte to develop and advance its product pipeline from discovery through late-stage clinical trials.
ALLOVIR
Social Links:
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2013-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.allovir.com
Total Employee:
101+
Status:
Active
Contact:
(346)772-0319
Email Addresses:
[email protected]
Total Funding:
360.59 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager Google Maps Content Delivery Network LetsEncrypt Amazon ReCAPTCHA
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Clene Nanomedicine
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - AlloVir
Invus
Invus investment in Post-IPO Equity - AlloVir
Kite Pharma
Kite Pharma investment in Post-IPO Equity - AlloVir
GMT Capital
GMT Capital investment in Post-IPO Equity - AlloVir
Redmile Group
Redmile Group investment in Post-IPO Equity - AlloVir
ElevateBio
ElevateBio investment in Post-IPO Equity - AlloVir
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - AlloVir
F2 Ventures
F2 Ventures investment in Post-IPO Equity - AlloVir
Fidelity
Fidelity investment in Series B - AlloVir
Leerink Partners
Leerink Partners investment in Series B - AlloVir
Key Employee Changes
| Date | New article |
|---|---|
| 2023-05-16 | AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer |
| 2021-12-16 | AlloVir Announces Departure of Chief Medical Officer Augustin Melian |
Official Site Inspections
http://www.allovir.com Semrush global rank: 6.25 M Semrush visits lastest month: 1.07 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "AlloVir"
AlloVir (ALVR) Company Profile & Description - Stock Analysis
Jul 30, 2020 Company profile for AlloVir, Inc. (ALVR) stock, with a description, list of executives, contact details and other key facts.See details»
AlloVir, Inc. - AnnualReports.com
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s innovative and …See details»
AlloVir - 2025 Company Profile & Team - Tracxn
Jul 6, 2025 AlloVir is a public company based in Houston (United States), founded in 2013 by David Hallal. It operates as a Developer of T-cell therapies to treat infectious diseases. AlloVir …See details»
AlloVir 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for AlloVir. Use the PitchBook Platform to explore the full profile.See details»
Investor Relations | AlloVir, Inc.
The Investor Relations website contains information about AlloVir, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Company Profile for AlloVir - Business Wire
Dec 10, 2020 AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in paSee details»
AlloVir - VentureRadar
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune …See details»
AlloVir, an ElevateBio Company Information - RocketReach
AlloVir, an ElevateBio Company is a Biotechnology Research, Biotechnology, and Pharmaceuticals company_reader located in Waltham, Massachusetts with $11.4 million in …See details»
Allovir Company Profile | Management and Employees List
Allovir Profile and History AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult …See details»
Company Profile for AlloVir - Nasdaq
Dec 10, 2020 AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely …See details»
AlloVir, Inc. Company Profile: Board of Directors, Capital Structure ...
Explore AlloVir, Inc. company profile, including board of directors, capital structure, raw materials, finished goods, stock DNA, and contact details. Get a complete overview of #company (ALVR).See details»
ALLOVIR: Shareholders Board Members Managers and Company …
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened …See details»
AlloVir Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 AlloVir has 4 employees across 3 locations. See insights on AlloVir including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AlloVir Inc company information, history, management and …
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy …See details»
Allovir Company Profile -Sales, Contacts, Competitors – Buzzfile
Allovir is located in Waltham, Massachusetts. This organization primarily operates in the Biological Products, except Diagnostic business / industry within the Chemicals and Allied Products …See details»
AlloVir | LinkedIn
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated …See details»
Allovir - Overview, News & Similar companies | ZoomInfo.com
Apr 4, 2024 View Allovir (www.allovir.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
AlloVir - businessabc.net
Jun 2, 2025 AlloVir was founded in 2013 as an early-stage biotechnology company focused on the development and commercialization of novel viral reduction technologies for organ …See details»
AlloVir: Revenue, Worth, Valuation & Competitors 2025
About AlloVir AlloVir is a Biotech related company based in Cambridge with 130 employees an estimated revenue of $22.6M, and. It has 10 competitors including Dermavant Sciences, …See details»
AlloVir, Inc. | Life Sciences PA
AlloVir is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened …See details»